A detailed history of Seven Bridge Financial Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Seven Bridge Financial Group, LLC holds 4,254 shares of AZN stock, worth $309,861. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,254
Previous 2,884 47.5%
Holding current value
$309,861
Previous $195,000 69.74%
% of portfolio
0.07%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$66.81 - $80.83 $91,529 - $110,737
1,370 Added 47.5%
4,254 $331,000
Q1 2024

May 10, 2024

BUY
$61.03 - $69.57 $176,010 - $200,639
2,884 New
2,884 $195,000
Q3 2019

Oct 09, 2019

SELL
$40.12 - $45.47 $66,799 - $75,707
-1,665 Closed
0 $0
Q3 2017

Nov 13, 2017

SELL
$28.96 - $34.0 $21,720 - $25,500
-750 Reduced 31.06%
1,665 $56,000
Q2 2017

Aug 14, 2017

BUY
N/A
2,415
2,415 $82,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $226B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Seven Bridge Financial Group, LLC Portfolio

Follow Seven Bridge Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Bridge Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seven Bridge Financial Group, LLC with notifications on news.